Skip to content

Gilead Sciences GILD Interest Expense

Interest Expense at other companies

Incyte logo
IncyteINCY
$569K-13.8%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$13.87M+2.5%
Precigen logo
PrecigenPGEN
$2.91M+290,700%
Celcuity logo
CelcuityCELC
$6.09M+91.2%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$3.62M+0.6%

Other financials

Income statement

See full
Revenue$7.0B+4.4%
Gross profit$5.5B+7.6%
Operating income$2.6B+15.6%
Net income$2.0B+53.7%
EPS (diluted)$1.61+54.8%

Balance sheet

See full
Cash & equivalents$7.6B-3.8%
Total debt$22.2B-11.1%
Total equity$23.5B+22.7%
Total assets$56.3B-0.3%

Cash flow

See full
Operating cash flow$2.5B+44.8%
CapEx$117.0M+12.5%
Free cash flow$2.4B+46.8%

Valuation

See full
Market cap$156.86B+21.7%
Enterprise value$171.41B+15.5%
P/E17×-3.4×
P/S5.3×+0.8×

Profitability

See full
Gross margin79.4%+1.1pp
Operating margin34.9%+6.3pp
Net margin31%+10.2pp
FCF margin34.4%+0.1pp

Returns & leverage

See full
Return on equity43.2%+10.7pp
Debt / equity0.9×-0.4×
Current ratio+0.6×

Where this comes from

Reported directly by Gilead Sciences in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gilead Sciences's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gilead Sciences's interest expense?
Gilead Sciences (GILD) reported interest expense of $240M in Q1 2026.
How has Gilead Sciences's interest expense changed year-over-year?
Gilead Sciences's interest expense decreased by 7.7% year-over-year, from $260M to $240M.
What is the long-term trend for Gilead Sciences's interest expense?
Over 4 years (2021 to 2025), Gilead Sciences's interest expense has grown at a 0.6% compound annual growth rate (CAGR), from $1B to $1.03B.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.